listen to yourself mate. There is no way back from here. Believe me, I have read all of the pre-clinical work cover to cover and it is impressive but this is now dead and buried. I’m not sure how many excuses and backflips one can be fed from management and continue to believe them. JC is a salesman.
big pharma will go absolutely no where near this thing. If they did PAB should be paying them, not the other way around.
what are the options from here?
License dx1 for what, a few mil max? Pay JC and co for some more months. Dx3 is a long way off phase 1.
cap raise at 2 cents?
honestly what is the play?
listen to yourself mate. There is no way back from here. Believe...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $10.97K | 3.626M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 31554019 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 27089307 | 15 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |